SLC6A2 Antikörper (Middle Region)
-
- Target Alle SLC6A2 Antikörper anzeigen
- SLC6A2 (Solute Carrier Family 6 (Neurotransmitter Transporter, Noradrenalin), Member 2 (SLC6A2))
-
Bindungsspezifität
- Middle Region
-
Reaktivität
- Ratte, Human, Maus, Kaninchen, Rind (Kuh), Hund, Pferd, Meerschweinchen
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser SLC6A2 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB)
- Sequenz
- STLSGSTFWA VVFFVMLLAL GLDSSMGGME AVITGLADDF QVLKRHRKLF
- Homologie
- Cow: 100%, Dog: 100%, Guinea Pig: 100%, Horse: 100%, Human: 100%, Mouse: 100%, Rabbit: 100%, Rat: 100%
- Produktmerkmale
- This is a rabbit polyclonal antibody against SLC6A2. It was validated on Western Blot using a cell lysate as a positive control.
- Aufreinigung
- Affinity Purified
- Immunogen
- The immunogen is a synthetic peptide directed towards the middle region of human SLC6A2
-
-
- Applikationshinweise
- Optimal working dilutions should be determined experimentally by the investigator.
- Kommentare
-
Antigen size: 617 AA
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- Lot specific
- Buffer
- Liquid. Purified antibody supplied in 1x PBS buffer with 0.09 % (w/v) sodium azide and 2 % sucrose.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Handhabung
- Avoid repeated freeze-thaw cycles.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- For short term use, store at 2-8°C up to 1 week. For long term storage, store at -20°C in small aliquots to prevent freeze-thaw cycles.
-
-
Epigenetic modification of the norepinephrine transporter gene in postural tachycardia syndrome." in: Arteriosclerosis, thrombosis, and vascular biology, Vol. 32, Issue 8, pp. 1910-6, (2012) (PubMed).
: "Combination of the serotonin transporter and norepinephrine transporter gene promoter polymorphisms might influence harm avoidance and novelty seeking in healthy females." in: Neuroscience letters, Vol. 439, Issue 1, pp. 52-5, (2008) (PubMed).
: "
-
Epigenetic modification of the norepinephrine transporter gene in postural tachycardia syndrome." in: Arteriosclerosis, thrombosis, and vascular biology, Vol. 32, Issue 8, pp. 1910-6, (2012) (PubMed).
-
- Target
- SLC6A2 (Solute Carrier Family 6 (Neurotransmitter Transporter, Noradrenalin), Member 2 (SLC6A2))
- Andere Bezeichnung
- SLC6A2 (SLC6A2 Produkte)
- Synonyme
- NAT1 antikoerper, NET antikoerper, NET1 antikoerper, SLC6A5 antikoerper, NE-T antikoerper, Slc6a5 antikoerper, Net antikoerper, SLC6A2 antikoerper, solute carrier family 6 member 2 antikoerper, solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 antikoerper, solute carrier family 6 member 5 antikoerper, SLC6A2 antikoerper, Slc6a2 antikoerper, SLC6A5 antikoerper
- Hintergrund
-
The SLC6A2 gene encodes a norepinephrine (noradrenaline) transporter, which is responsible for reuptake of norepinephrine into presynaptic nerve terminals and is a regulator of norepinephrine homeostasis.The SLC6A2 gene encodes a norepinephrine (noradrenaline) transporter, which is responsible for reuptake of norepinephrine into presynaptic nerve terminals and is a regulator of norepinephrine homeostasis (Kim et al., 2006 [PubMed 17146058]).[supplied by OMIM]. Publication Note: This RefSeq record includes a subset of the publications that are available for this gene. Please see the Entrez Gene record to access additional publications.
Alias Symbols: NAT1, NET, NET1, SLC6A5
Protein Interaction Partner: SNCA, ACTB, STX1A, PPP2R1A,
Protein Size: 617 - Molekulargewicht
- 69 kDa
- Gen-ID
- 6530
- NCBI Accession
- NM_001043, NP_001034
- UniProt
- P23975
-